{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T03:42:59Z","timestamp":1790048579507,"version":"4.0.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000024","name":"CIHR","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intensive Care Med"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s00134-020-05949-z","type":"journal-article","created":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T10:02:57Z","timestamp":1581588177000},"page":"285-297","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Treatment of Ebola-related critical illness"],"prefix":"10.1007","volume":"46","author":[{"given":"Peter","family":"Kiiza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Mullin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Teo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4038-5382","authenticated-orcid":false,"given":"N. K. J.","family":"Adhikari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1002-2989","authenticated-orcid":false,"given":"R. A.","family":"Fowler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,13]]},"reference":[{"issue":"7","key":"5949_CR1","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1164\/rccm.201408-1514CP","volume":"190","author":"RA Fowler","year":"2014","unstructured":"Fowler RA, Fletcher T, Fischer WA, Lamontagne F, Jacob S, Brett-Major D, Lawler JV, Jacquerioz FA, Houlihan C, O\u2019Dempsey T, Ferri M (2014) Caring for critically ill patients with Ebola virus disease. Perspectives from West Africa. Am J Respir Crit Care Med 190(7):733\u2013737","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"5949_CR2","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s13054-016-1325-2","volume":"20","author":"A Leligdowicz","year":"2016","unstructured":"Leligdowicz A, Fischer WA, Uyeki TM, Fletcher TE, Adhikari NK, Portella G, Lamontagne F, Clement C, Jacob ST, Rubinson L, Vanderschuren A (2016) Ebola virus disease and critical illness. Crit Care 20(1):217","journal-title":"Crit Care"},{"issue":"17","key":"5949_CR3","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1056\/NEJMp1411310","volume":"371","author":"F Lamontagne","year":"2014","unstructured":"Lamontagne F, Cl\u00e9ment C, Fletcher T, Jacob ST, Fischer WA, Fowler RA (2014) Doing today's work superbly well\u2014treating Ebola with current tools. N Engl J Med 371(17):1565\u20131566","journal-title":"N Engl J Med"},{"issue":"10174","key":"5949_CR4","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/S0140-6736(18)33132-5","volume":"393","author":"D Malvy","year":"2019","unstructured":"Malvy D, McElroy AK, de Clerck H, G\u00fcnther S, van Griensven J (2019) Ebola virus disease. Lancet 393(10174):936\u2013948","journal-title":"Lancet"},{"issue":"10172","key":"5949_CR5","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/S0140-6736(19)30242-9","volume":"393","author":"F Lamontagne","year":"2019","unstructured":"Lamontagne F, Cl\u00e9ment C, Kojan R, Godin M, Kabuni P, Fowler RA (2019) The evolution of supportive care for Ebola virus disease. Lancet 393(10172):620\u2013621","journal-title":"Lancet"},{"issue":"9","key":"5949_CR6","doi-asserted-by":"publisher","first-page":"e280","DOI":"10.1016\/S1473-3099(17)30234-7","volume":"17","author":"A Rojek","year":"2017","unstructured":"Rojek A, Horby P, Dunning J (2017) Insights from clinical research completed during the west Africa Ebola virus disease epidemic. Lancet Infect Dis 17(9):e280\u2013e292","journal-title":"Lancet Infect Dis"},{"key":"5949_CR7","doi-asserted-by":"publisher","first-page":"g7348","DOI":"10.1136\/bmj.g7348","volume":"349","author":"NJ Beeching","year":"2014","unstructured":"Beeching NJ, Fenech M, Houlihan CF (2014) Ebola virus disease. BMJ 349:g7348","journal-title":"BMJ"},{"issue":"11","key":"5949_CR8","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1016\/S1473-3099(15)00144-9","volume":"15","author":"L Hunt","year":"2015","unstructured":"Hunt L, Gupta-Wright A, Simms V, Tamba F, Knott V, Tamba K, Heisenberg-Mansaray S, Tamba E, Sheriff A, Conteh S, Smith T (2015) Clinical presentation, biochemical, and haematological parameters and their association with outcome in patients with Ebola virus disease: an observational cohort study. Lancet Infect Dis 15(11):1292\u20131299","journal-title":"Lancet Infect Dis"},{"issue":"10121","key":"5949_CR9","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/S0140-6736(17)31795-6","volume":"391","author":"F Lamontagne","year":"2018","unstructured":"Lamontagne F, Fowler RA, Adhikari NK, Murthy S, Brett-Major DM, Jacobs M, Uyeki TM, Vallenas C, Norris SL, Fischer WA 2nd, Fletcher TE (2018) Evidence-based guidelines for supportive care of patients with Ebola virus disease. Lancet 391(10121):700\u2013708","journal-title":"Lancet"},{"issue":"1","key":"5949_CR10","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.idc.2018.10.013","volume":"33","author":"C Cl\u00e9ment","year":"2019","unstructured":"Cl\u00e9ment C, Adhikari NK, Lamontagne F (2019) Evidence-based clinical management of Ebola virus disease and epidemic viral hemorrhagic fevers. Infect Dis Clin 33(1):247\u2013264","journal-title":"Infect Dis Clin"},{"key":"5949_CR11","unstructured":"World Health Organization (2019) Optimized supportive care for ebola virus disease: clinical management standard operating procedures. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/325000\/9789241515894-eng.pdf?sequence=1. Accessed 17 Nov 2019"},{"issue":"7","key":"5949_CR12","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1056\/NEJMoa1504874","volume":"374","author":"TM Uyeki","year":"2016","unstructured":"Uyeki TM, Mehta AK, Davey RT Jr, Liddell AM, Wolf T, Vetter P, Schmiedel S, Gr\u00fcnewald T, Jacobs M, Arribas JR, Evans L (2016) Clinical management of Ebola virus disease in the United States and Europe. N Engl J Med 374(7):636\u2013646","journal-title":"N Engl J Med"},{"key":"5949_CR13","unstructured":"Centers for Disease Prevention and Control: Ebola (Ebola Virus Disease). Outbreaks. https:\/\/www.cdc.gov\/vhf\/ebola\/outbreaks\/index-2018.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fvhf%2Febola%2Foutbreaks%2Findex.html. Accessed 17 Nov 2019"},{"key":"5949_CR14","unstructured":"World Health Organization. Clinical management of patients with viral hemorrhagic fever: a pocket guide for front-line health workers: interim emergency guidance for country adaptation. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/205570\/?sequence=1. Accessed 17 Nov 2019"},{"key":"5949_CR15","unstructured":"National Institute of Allergy and Infectious Diseases (2019) Independent monitoring board recommends early termination of Ebola therapeutics trial in DRC because of favorable results with two of four candidates. https:\/\/www.niaid.nih.gov\/news-events\/independent-monitoring-board-recommends-early-termination-ebola-therapeutics-trial-drc. Accessed 17 Nov 2019"},{"issue":"4","key":"5949_CR16","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jinf.2017.12.006","volume":"76","author":"SJ Dickson","year":"2018","unstructured":"Dickson SJ, Clay KA, Adam M, Ardley C, Bailey MS, Burns DS, Cox AT, Craig DG, Espina M, Ewington I, Fitchett G (2018) Enhanced case management can be delivered for patients with EVD in Africa: experience from a UK military Ebola treatment centre in Sierra Leone. J Infect 76(4):383\u2013392","journal-title":"J Infect"},{"key":"5949_CR17","unstructured":"World Health Organization (2019). Ebola in the DRC. Health Emergency update. https:\/\/www.who.int\/emergencies\/diseases\/ebola\/drc-2019. Accessed 04 Jan 2020"},{"key":"5949_CR18","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1056\/NEJMsr1904253","volume":"381","author":"O Ilunga Kalenga","year":"2019","unstructured":"Ilunga Kalenga O, Moeti M, Sparrow A, Nguyen VK, Lucey D, Ghebreyesus TA (2019) The ongoing Ebola epidemic in the Democratic Republic of Congo, 2018\u20132019. N Engl J Med 381:373\u2013383","journal-title":"N Engl J Med"},{"key":"5949_CR19","unstructured":"World Health Organization. Ebola virus disease. Key facts. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/ebola-virus-disease. Accessed 17 Nov 2019"},{"key":"5949_CR20","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41579-019-0187-4","volume":"5","author":"JH Kuhn","year":"2019","unstructured":"Kuhn JH, Adachi T, Adhikari NK, Arribas JR, Bah IE, Bausch DG, Bhadelia N, Borchert M, Brants\u00e6ter AB, Brett-Major DM, Burgess TH (2019) New filovirus disease classification and nomenclature. Nat Rev Microbiol 5:261","journal-title":"Nat Rev Microbiol"},{"key":"5949_CR21","unstructured":"World Health Organization. Ebola situation reports. https:\/\/www.who.int\/publications-detail\/ebola-virus-disease-democratic-republic-of-congo-external-situation-report-67-2019. Accessed 17 Nov 2019"},{"issue":"9992","key":"5949_CR22","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/S0140-6736(15)61446-5","volume":"386","author":"JR Glynn","year":"2015","unstructured":"Glynn JR (2015) Age-specific incidence of Ebola virus disease. Lancet 386(9992):432","journal-title":"Lancet"},{"key":"5949_CR23","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1146\/annurev-pathol-052016-100506","volume":"12","author":"L Baseler","year":"2017","unstructured":"Baseler L, Chertow DS, Johnson KM, Feldmann H, Morens DM (2017) The pathogenesis of Ebola virus disease. Annu Rev Pathol 12:387\u2013418","journal-title":"Annu Rev Pathol"},{"issue":"10","key":"5949_CR24","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1093\/cid\/ciw601","volume":"63","author":"B Diallo","year":"2016","unstructured":"Diallo B, Sissoko D, Loman NJ, Bah HA, Bah H, Worrell MC, Conde LS, Sacko R, Mesfin S, Loua A, Kalonda JK (2016) Resurgence of Ebola virus disease in Guinea linked to a survivor with virus persistence in seminal fluid for more than 500 days. Clin Infect Dis 63(10):1353\u20131356","journal-title":"Clin Infect Dis"},{"key":"5949_CR25","first-page":"141","volume":"411","author":"C Munoz-Fontela","year":"2017","unstructured":"Munoz-Fontela C, McElroy AK (2017) Ebola virus disease in humans: pathophysiology and immunity. Curr Top Microbiol Immunol 411:141\u2013169","journal-title":"Curr Top Microbiol Immunol"},{"key":"5949_CR26","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.coviro.2018.01.010","volume":"28","author":"AK McElroy","year":"2018","unstructured":"McElroy AK, M\u00fchlberger E, Munoz-Fontela C (2018) Immune barriers of Ebola virus infection. Curr Opin Virol 28:152\u2013160","journal-title":"Curr Opin Virol"},{"issue":"4","key":"5949_CR27","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1128\/jvi.70.4.2208-2214.1996","volume":"70","author":"H Feldmann","year":"1996","unstructured":"Feldmann H, Bugany H, Mahner F, Klenk HD, Drenckhahn D, Schnittler HJ (1996) Filovirus-induced endothelial leakage triggered by infected monocytes\/macrophages. J Virol 70(4):2208\u20132214","journal-title":"J Virol"},{"key":"5949_CR28","unstructured":"World Health Organization (2017) Ebola key technical documents. https:\/\/www.who.int\/ebola\/22-5-17-Ebola-Key-technical-documents-EN.pdf?ua=1. Accessed 17 Nov 2019"},{"issue":"1","key":"5949_CR29","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.phrp.2011.04.001","volume":"2","author":"M Eichner","year":"2011","unstructured":"Eichner M, Dowell SF, Firese N (2011) Incubation period of Ebola hemorrhagic virus subtype Zaire. Osong Public Health Res Perspect 2(1):3\u20137","journal-title":"Osong Public Health Res Perspect"},{"issue":"11","key":"5949_CR30","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1016\/j.cmi.2019.06.032","volume":"25","author":"AM Rojek","year":"2019","unstructured":"Rojek AM, Salam A, Ragotte RJ, Liddiard E, Elhussain A, Carlqvist A, Butler M, Kayem N, Castle L, Lang\u2019o O, Stepniewska K (2019) A systematic review and meta-analysis of patient data from the west Africa (2013\u201316) Ebola virus disease epidemic. Clin Microbiol Infect 25(11):1307\u20131314","journal-title":"Clin Microbiol Infect"},{"issue":"9","key":"5949_CR31","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/S1473-3099(15)00137-1","volume":"15","author":"M Lado","year":"2015","unstructured":"Lado M, Walker NF, Baker P, Haroon S, Brown CS, Youkee D, Studd N, Kessete Q, Maini R, Boyles T, Hanciles E (2015) Clinical features of patients isolated for suspected Ebola virus disease at Connaught Hospital, Freetown, Sierra Leone: a retrospective cohort study. Lancet Infect Dis 15(9):1024\u20131033","journal-title":"Lancet Infect Dis"},{"issue":"22","key":"5949_CR32","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1056\/NEJMp1413084","volume":"371","author":"DS Chertow","year":"2014","unstructured":"Chertow DS, Kleine C, Edwards JK, Scaini R, Giuliani R, Sprecher A (2014) Ebola virus disease in West Africa\u2014clinical manifestations and management. N Engl J Med 371(22):2054\u20132057","journal-title":"N Engl J Med"},{"issue":"3","key":"5949_CR33","doi-asserted-by":"publisher","first-page":"96","DOI":"10.4103\/ajm.AJM_150_16","volume":"7","author":"MT Khalafallah","year":"2017","unstructured":"Khalafallah MT, Aboshady OA, Moawed SA, Ramadan MS (2017) Ebola virus disease: essential clinical knowledge. Avicenna J Med 7(3):96","journal-title":"Avicenna J Med"},{"key":"5949_CR34","unstructured":"World Health Organization (2015) Interim Guidance on the use of rapid antigen detection tests. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/160265\/WHO_EVD_HIS_EMP_15.1_eng.pdf?sequence=1. Accessed 17 Nov 2019"},{"issue":"4","key":"5949_CR35","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1080\/14737159.2019.1595592","volume":"19","author":"J Tembo","year":"2019","unstructured":"Tembo J, Simulundu E, Changula K, Handley D, Gilbert M, Chilufya M, Asogun D, Ansumana R, Kapata N, Ntoumi F, Ippolito G (2019) Recent advances in the development and evaluation of molecular diagnostics for Ebola virus disease. Expert Rev Mol Diagn 19(4):325\u2013340","journal-title":"Expert Rev Mol Diagn"},{"key":"5949_CR36","unstructured":"World Health Organization (2015) Selection and use of Ebola in vitro diagnostic assays. Emergency guidance. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/175554\/WHO_EVD_HIS_EMP_15.2_annex_eng.pdf?sequence=2. Accessed 17 Nov 2019"},{"issue":"1","key":"5949_CR37","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s13149-016-0540-z","volume":"110","author":"F Gallais","year":"2017","unstructured":"Gallais F, Gay-Andrieu F, Picot V, Magassouba N, M\u00e9ly S, Peyrefitte CN, Bellanger L (2017) Field assessment of the new rapid diagnostic test Ebola eZYSCREEN\u00ae. Bull Soc Pathol Exot (1990) 110(1):38\u201348","journal-title":"Bull Soc Pathol Exot (1990)"},{"issue":"12","key":"5949_CR38","doi-asserted-by":"publisher","first-page":"21073","DOI":"10.2807\/1560-7917.ES2015.20.12.21073","volume":"20","author":"NF Walker","year":"2015","unstructured":"Walker NF, Brown CS, Youkee D, Baker P, Williams N, Kalawa A, Russell K, Samba AF, Bentley N, Koroma F, King MB (2015) Evaluation of a point-of-care blood test for identification of Ebola virus disease at Ebola holding units, Western Area, Sierra Leone, January to February 2015. Eurosurveillance 20(12):21073","journal-title":"Eurosurveillance"},{"key":"5949_CR39","first-page":"129","volume":"19","author":"GA Engwa","year":"2018","unstructured":"Engwa GA (2018) Ebola virus disease: progress so far in the management of the disease. Curr Top Trop Emerg Dis Travel Med 19:129","journal-title":"Curr Top Trop Emerg Dis Travel Med"},{"issue":"7","key":"5949_CR40","doi-asserted-by":"publisher","first-page":"589","DOI":"10.3390\/v11070589","volume":"11","author":"S Makiala","year":"2019","unstructured":"Makiala S, Mukadi D, De Weggheleire A, Muramatsu S, Kato D, Inano K, Gondaira F, Kajihara M, Yoshida R, Changula K, Mweene A (2019) Clinical evaluation of QuickNaviTM-Ebola in the 2018 outbreak of Ebola virus disease in the Democratic Republic of the Congo. Viruses 11(7):589","journal-title":"Viruses"},{"issue":"4","key":"5949_CR41","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.ccc.2019.06.011","volume":"35","author":"P Kiiza","year":"2019","unstructured":"Kiiza P, Adhikari NK, Mullin S, Teo K, Fowler RA (2019) Principles and practices of establishing a hospital-based Ebola treatment unit. Crit Care Clin 35(4):697\u2013710","journal-title":"Crit Care Clin"},{"issue":"10068","key":"5949_CR42","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0140-6736(16)32621-6","volume":"389","author":"AM Henao-Restrepo","year":"2017","unstructured":"Henao-Restrepo AM, Camacho A, Longini IM, Watson CH, Edmunds WJ, Egger M, Carroll MW, Dean NE, Diatta I, Doumbia M, Draguez B (2017) Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola \u00c7a Suffit!). Lancet 389(10068):505\u2013518","journal-title":"Lancet"},{"key":"5949_CR43","unstructured":"World Health Organization (2019) Vaccination. Preliminary results on the efficacy of rVSV-ZEBOV-GP Ebola vaccine using the ring vaccination strategy in the control of an Ebola outbreak in the Democratic Republic of the Congo: an example of integration of research into epidemic response. https:\/\/www.who.int\/csr\/resources\/publications\/ebola\/ebola-ring-vaccination-results-12-april-2019.pdf?ua=1. Accessed 17 Nov 2019"},{"issue":"21","key":"5949_CR44","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1056\/NEJMp1811751","volume":"379","author":"IK Damon","year":"2018","unstructured":"Damon IK, Rollin PE, Choi MJ, Arthur RR, Redfield RR (2018) New tools in the Ebola arsenal. N Engl J Med 379(21):1981\u20131983","journal-title":"N Engl J Med"},{"issue":"15","key":"5949_CR45","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1056\/NEJMoa1604330","volume":"375","author":"Prevail II Writing Group","year":"2016","unstructured":"Prevail II Writing Group (2016) A randomized, controlled trial of ZMapp for Ebola virus infection. New Engl J Med 375(15):1448\u201356","journal-title":"New Engl J Med"},{"issue":"6","key":"5949_CR46","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1056\/NEJMc1413685","volume":"372","author":"R Ansumana","year":"2015","unstructured":"Ansumana R, Jacobsen KH, Idris MB, Bangura H, Boie-Jalloh M, Lamin JM, Sesay S, Sahr F (2015) Ebola in Freetown area, Sierra Leone\u2014a case study of 581 patients. N Engl J Med 372(6):587\u2013588","journal-title":"N Engl J Med"},{"issue":"1","key":"5949_CR47","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1681\/ASN.2014111057","volume":"26","author":"MJ Connor","year":"2015","unstructured":"Connor MJ, Kraft C, Mehta AK, Varkey JB, Lyon GM, Crozier I, Str\u00f6her U, Ribner BS, Franch HA (2015) Successful delivery of RRT in Ebola virus disease. J Am Soc Nephrol 26(1):31\u201337","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"5949_CR48","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1186\/s12879-019-3980-9","volume":"19","author":"JS Lee","year":"2019","unstructured":"Lee JS, Adhikari NK, Kwon HY, Teo K, Siemieniuk R, Lamontagne F, Chan A, Mishra S, Murthy S, Kiiza P, Hajek J et al (2019) Anti-Ebola therapy for patients with Ebola virus disease: a systematic review. BMC Infect Dis 19(1):376","journal-title":"BMC Infect Dis"},{"key":"5949_CR49","unstructured":"World Health Organization (2018) WHO R&D Blueprint\u2014Ad-hoc Expert Consultation on clinical trials for Ebola Therapeutics. https:\/\/www.who.int\/ebola\/drc-2018\/treatments-approved-for-compassionate-use-update\/en\/. Accessed 17 Nov 2019"},{"issue":"8","key":"5949_CR50","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/S1473-3099(18)30397-9","volume":"18","author":"S Sivapalasingam","year":"2018","unstructured":"Sivapalasingam S, Kamal M, Slim R, Hosain R, Shao W, Stoltz R, Yen J, Pologe LG, Cao Y, Partridge M, Sumner G (2018) Safety, pharmacokinetics, and immunogenicity of a co-formulated cocktail of three human monoclonal antibodies targeting Ebola virus glycoprotein in healthy adults: a randomized, first-in-human phase 1 study. Lancet Infect Dis 18(8):884\u2013893","journal-title":"Lancet Infect Dis"},{"issue":"10174","key":"5949_CR51","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0140-6736(19)30036-4","volume":"393","author":"MR Gaudinski","year":"2019","unstructured":"Gaudinski MR, Coates EE, Novik L, Widge A, Houser KV, Burch E, Holman LA, Gordon IJ, Chen GL, Carter C, Nason M (2019) Safety, tolerability, pharmacokinetics, and immunogenicity of the therapeutic monoclonal antibody mAb114 targeting Ebola virus glycoprotein (VRC 608): an open-label phase 1 study. Lancet 393(10174):889\u2013898","journal-title":"Lancet"},{"issue":"24","key":"5949_CR52","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1056\/NEJMoa1910993","volume":"381","author":"S Mulangu","year":"2019","unstructured":"Mulangu S, Dodd LE, Davey RT Jr, Tshiani Mbaya O, Proschan M, Mukadi D, Lusakibanza Manzo M, Nzolo D, Tshomba Oloma A, Ibanda A, Ali R (2019) A randomized, controlled trial of Ebola virus disease therapeutics. N Engl J Med 381(24):2293\u20132303","journal-title":"N Engl J Med"},{"key":"5949_CR53","doi-asserted-by":"crossref","unstructured":"Warren T, Jordan R, Lo M, Soloveva V, Ray A, Bannister R, Mackman R, Perron M, Stray K, Feng J, Xu Y (2015) Nucleotide prodrug GS-5734 is a broad-spectrum filovirus inhibitor that provides complete therapeutic protection against the development of Ebola virus disease (EVD) in infected non-human primates. Infectious Diseases Society of America Open Forum Infectious Diseases 2(1) LB-2. https:\/\/academic.oup.com\/ofid\/article\/2\/suppl_1\/LB-2\/2633814. Accessed 17 Nov 2019","DOI":"10.1093\/ofid\/ofv130.02"},{"issue":"10043","key":"5949_CR54","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/S0140-6736(16)30386-5","volume":"388","author":"M Jacobs","year":"2016","unstructured":"Jacobs M, Rodger A, Bell DJ, Bhagani S, Cropley I, Filipe A, Gifford RJ, Hopkins S, Hughes J, Jabeen F, Johannessen I (2016) Late Ebola virus relapse causing meningoencephalitis: a case report. Lancet 388(10043):498\u2013503","journal-title":"Lancet"},{"issue":"2","key":"5949_CR55","first-page":"171","volume":"215","author":"J D\u00f6rnemann","year":"2017","unstructured":"D\u00f6rnemann J, Burzio C, Ronsse A, Sprecher A, De Clerck H, Van Herp M, Koli\u00e9 MC, Yosifiva V, Caluwaerts S, McElroy AK, Antierens A (2017) First newborn baby to receive experimental therapies survives Ebola virus disease. J Infect Dis 215(2):171\u2013174","journal-title":"J Infect Dis"}],"container-title":["Intensive Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-020-05949-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00134-020-05949-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-020-05949-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,16]],"date-time":"2022-04-16T10:04:06Z","timestamp":1650103446000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00134-020-05949-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["5949"],"URL":"https:\/\/doi.org\/10.1007\/s00134-020-05949-z","relation":{},"ISSN":["0342-4642","1432-1238"],"issn-type":[{"value":"0342-4642","type":"print"},{"value":"1432-1238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"19 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}